01 1Nobilus Ent Tomasz Kozluk
01 1Masung LS Co., Ltd.
01 1Digoxin
01 1Poland
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-03-09
Registration Number : 20210309-209-J-739
Manufacturer Name : Nobilus Ent Tomasz Kozluk
Manufacturer Address : ul. Metalowa 6a, 99-300 Kutno, Poland
42
PharmaCompass offers a list of Digoxin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Digoxin manufacturer or Digoxin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Digoxin manufacturer or Digoxin supplier.
A Lanacrist manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanacrist, including repackagers and relabelers. The FDA regulates Lanacrist manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanacrist API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lanacrist manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lanacrist supplier is an individual or a company that provides Lanacrist active pharmaceutical ingredient (API) or Lanacrist finished formulations upon request. The Lanacrist suppliers may include Lanacrist API manufacturers, exporters, distributors and traders.
click here to find a list of Lanacrist suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lanacrist Drug Master File in Korea (Lanacrist KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lanacrist. The MFDS reviews the Lanacrist KDMF as part of the drug registration process and uses the information provided in the Lanacrist KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lanacrist KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lanacrist API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lanacrist suppliers with KDMF on PharmaCompass.
